Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa

JAMA Dermatol. 2020 Mar 1;156(3):342-345. doi: 10.1001/jamadermatol.2019.4590.

Maria C Schneeweiss^{1

2}, Seoyoung C Kim^{2

3}, Sebastian Schneeweiss², David Rosmarin⁴, Joseph F Merola^{1

3}

¹ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Department of Dermatology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.

Abstract

This cohort study evaluates the risk of developing inflammatory arthritis among patients with hidradenitis suppurativa.